Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

UK Microbiology Market 2017-2021 Forecasts and Supplier Shares - Continuing Spread of AIDS is One of the Main Driving Forces - Research and Markets

Research and Markets
Posted on: 15 Jan 18

The "UK Microbiology Market Forecasts and Supplier Shares 2017-2021: Emerging Opportunities and Growth Strategies for Instrument and Reagent Suppliers" report has been added to ResearchAndMarkets.com's offering.

A new strategic analysis of major business opportunities will emerge in the infectious disease testing market during the next five years.

This comprehensive report will assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding microbiology testing market, by evaluating emerging opportunities and developing effective business strategies.

Microbiology testing is one of the most rapidly growing segments of the in vitro diagnostics industry, and the greatest challenge facing suppliers during this decade. Among the main driving forces is the continuing spread of AIDS, which remains the world's major health threat and a key factor contributing to the rise of opportunistic infections, the threat of bioterrorism, advances in molecular diagnostic technologies, and the wider availability of immunosuppressive drugs.

Although for some infections the etiology is still a mystery, for others the causative microorganisms are present in minute concentrations long before the occurrence of first clinical symptoms, and recent advances in genetic engineering and detection technologies are creating exciting opportunities for highly sensitive, specific and cost-effective products.

Market Segmentation Analysis

Sales and market shares of major suppliers by individual test.

Volume and sales forecasts for over 100 infectious disease assays by individual test and market segment:

  • Hospitals Blood Banks Commercial/Private Laboratories Public Health Laboratories
  • Test volume estimates by method (molecular, serology/immunodiagnostics, culture/microscopy).
  • Review of the market dynamics, trends, structure, size, growth and major suppliers.

Companies Mentioned:

  • Abbott
  • Affymetrix
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Bio-Rad
  • bioMerieux
  • Cepheid
  • Diamedix/Erba
  • DiaSorin
  • Eiken Chemical
  • Elitech Group
  • Enzo Biochem
  • Fujirebio
  • Grifols
  • Hologic/Gen-Probe
  • ID Biomedical/GSK
  • Kreatech/Leica
  • Lonza
  • Ortho-Clinical Diagnostics
  • Qiagen
  • Roche
  • Scienion
  • Sequenom
  • SeraCare
  • Siemens
  • Takara Bio
  • Thermo Fisher
  • Wako
  • Wallac/PE

Key Topics Covered:

1. Introduction

2. Worldwide Market Overview

3. Major Product Development Opportunities

4. Design Criteria for Decentralized Testing Products

5. Alternative Market Penetration Strategies

6. Potential Market Entry Barriers and Risks

7. Worldwide Overview of Major Tests,

8. U.K. Infectious Disease Testing Market

9. Competitive Analysis

For more information about this report visit https://www.researchandmarkets.com/research/l7h276/uk_microbiology?w=4

View source version on businesswire.com: http://www.businesswire.com/news/home/20180115005307/en/

Business Wire
www.businesswire.com

Last updated on: 15/01/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.